Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jan;32(1):e16181.
doi: 10.1111/ene.16181. Epub 2024 Feb 20.

Cognitive domains affected post-COVID-19; a systematic review and meta-analysis

Affiliations
Meta-Analysis

Cognitive domains affected post-COVID-19; a systematic review and meta-analysis

Jack B Fanshawe et al. Eur J Neurol. 2025 Jan.

Erratum in

Abstract

Background and purpose: This review aims to characterize the pattern of post-COVID-19 cognitive impairment, allowing better prediction of impact on daily function to inform clinical management and rehabilitation.

Methods: A systematic review and meta-analysis of neurocognitive sequelae following COVID-19 was conducted, following PRISMA-S guidelines. Studies were included if they reported domain-specific cognitive assessment in patients with COVID-19 at >4 weeks post-infection. Studies were deemed high-quality if they had >40 participants, utilized healthy controls, had low attrition rates and mitigated for confounders.

Results: Five of the seven primary Diagnostic and Statistical Manual of Mental Disorders (DSM-5) cognitive domains were assessed by enough high-quality studies to facilitate meta-analysis. Medium effect sizes indicating impairment in patients post-COVID-19 versus controls were seen across executive function (standardised mean difference (SMD) -0.45), learning and memory (SMD -0.55), complex attention (SMD -0.54) and language (SMD -0.54), with perceptual motor function appearing to be impacted to a greater degree (SMD -0.70). A narrative synthesis of the 56 low-quality studies also suggested no obvious pattern of impairment.

Conclusions: This review found moderate impairments across multiple domains of cognition in patients post-COVID-19, with no specific pattern. The reported literature was significantly heterogeneous, with a wide variety of cognitive tasks, small sample sizes and disparate initial disease severities limiting interpretability. The finding of consistent impairment across a range of cognitive tasks suggests broad, as opposed to domain-specific, brain dysfunction. Future studies should utilize a harmonized test battery to facilitate inter-study comparisons, whilst also accounting for the interactions between COVID-19, neurological sequelae and mental health, the interplay between which might explain cognitive impairment.

Keywords: COVID‐19; attention; cognition; cognitive impairment; executive function; language; learning; memory.

PubMed Disclaimer

Conflict of interest statement

BDM declares payments for the UMASS lecture 2023 and for medicolegal work unrelated to the topic of this manuscript or the manuscript itself. BDM is also the Encephalitis Society Vice Chair for which he receives no remuneration. AC has received a CSO Scotland grant for cognitive phenotyping of post‐covid symptoms for work unrelated to this manuscript. AC has been a Virginia University Grand Rounds speaker honorarium on functional cognitive disorders and has received payment for expert testimony on a range of neuropsychiatric topics unrelated to this manuscript. AC is also a paid editor for the Journal of Neurology, Neurosurgery and Psychiatry and a president of FND society for which he receives no remuneration. S‐MP reports receiving travel reimbursement for acting as an invited speaker at two conferences; (1) International Brain Research Organisation—Regional African Neurology Training (2023) and (2) Alzheimer's Association—Dementia in LMICs (2022). S‐MP also sits on the executive committee of the RCPsych VIPSIG, an unpaid role. KS has received support from the Tanzanian Medical Students Association for support to attend academic conferences unrelated to this work. ASD is supported by the NIHR Biomedical Research Centre, University College Hospital London and is the president of the International Neuropsychiatric Association. JPR acknowledges a grant from the Wellcome trust paid to his institution to cover salary and research expenses for work unrelated to this manuscript. MT acknowledges grants from the MQ Mental Health Research and Wolfson Foundation to investigate mechanisms of post‐COVID cognitive deficits. AH is co‐founder and director of H2CD Inc, a software company that provides online assessment technology for research and healthcare purposes unrelated to this manuscript. GKW, KT, BFS, CN, JBF, DA, BM, SP, AP, ZUH, EB, AS, ECL, EK, TRN, JBB, IC have no COI to declare.

Figures

FIGURE 1
FIGURE 1
Forest plot of meta‐analysed SMDs for executive function test scores of patients post‐COVID‐19 disease and healthy controls.
FIGURE 2
FIGURE 2
Forest plot of meta‐analysed SMDs for learning and memory test scores of patients post‐COVID‐19 disease and healthy controls.
FIGURE 3
FIGURE 3
Forest plot of meta‐analysed SMDs for perceptual motor function test scores of patients post‐COVID‐19 disease and healthy controls.
FIGURE 4
FIGURE 4
Forest plot of meta‐analysed SMDs for language test scores of patients post‐COVID‐19 disease and healthy controls.
FIGURE 5
FIGURE 5
Forest plot of meta‐analysed SMDs for complex attention test scores of patients post‐COVID‐19 disease and healthy controls.

References

    1. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta‐analysis with comparison to the COVID‐19 pandemic. Lancet Psychiatry. 2020;7:611‐627. - PMC - PubMed
    1. Rogers JP, Watson CJ, Badenoch J, et al. Neurology and neuropsychiatry of COVID‐19: a systematic review and meta‐analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry. 2021;92:932‐941. - PubMed
    1. Badenoch JB, Rengasamy ER, Watson C, et al. Persistent neuropsychiatric symptoms after COVID‐19: a systematic review and meta‐analysis. Brain Commun. 2021;4:fcab297. - PMC - PubMed
    1. NICE . COVID‐19 rapid guideline: managing the long‐term effects of COVID‐19. NICE; 2022. - PubMed
    1. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post‐COVID‐19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102‐e107. - PMC - PubMed

REFERENCES FOR SYSTEMATIC REVIEW'S INCLUDED STUDIES

    1. Aiello EN, Fiabane E, Manera MR, et al. Episodic long‐term memory in post‐infectious SARS‐CoV‐2 patients. Neurol Sci. 2022;43(2):785‐788. - PMC - PubMed
    1. Albu S, Rivas Zozaya N, Murillo N, García‐Molina A, Figueroa Chacón CA, Kumru H. Multidisciplinary outpatient rehabilitation of physical and neurological sequelae and persistent symptoms of COVID‐19: a prospective, observational cohort study. Disabil Rehabil. 2022;44(22):6833‐6840. - PubMed
    1. Albu S, Zozaya NR, Murillo N, García‐Molina A, Chacón CAF, Kumru H. What's going on following acute COVID‐19? Clinical characteristics of patients in an out‐patient rehabilitation program. NRE. 2021;48(4):469‐480. - PubMed
    1. Andrei Appelt P, Taciana Sisconetto A, Baldo Sucupira KSM, et al. Changes in electrical brain activity and cognitive functions following mild to moderate COVID‐19: a one‐year prospective study after acute infection. Clin EEG Neurosci. 2022;53(6):543‐557. - PMC - PubMed
    1. Andriuta D, Si‐Ahmed C, Roussel M, et al. Clinical and imaging determinants of neurocognitive disorders in post‐acute COVID‐19 patients with cognitive complaints. J Alzheimers Dis. 2022;87:1239‐1250. - PubMed

MeSH terms